P/B
1,4
Sensus Healthcare
Sensus Healthcare Inc is engaged in manufacturing a superficial radiotherapy system. These devices are used for treating both oncological and non-oncological skin conditions including basal cell and squamous cell skin cancers and other skin conditions such as keloids. Its product includes SRT-100, SRT-100 vision, and a sentinel service program. The company's revenue is generated majorly from customers in the United States.
Sensus Healthcare Inc is engaged in manufacturing a superficial radiotherapy system. These devices are used for treating both oncological and non-oncological skin conditions including basal cell and squamous cell skin cancers and other skin conditions such as keloids. Its product includes SRT-100, SRT-100 vision, and a sentinel service program. The company's revenue is generated majorly from customers in the United States.
$52.1M
Market Cap • 9/11/2026
2010
(16 years)
Founded
2016
(10 years ago)
IPO
NASDAQ
Listing Exchange
United States
Country
Valuation
P/S
3
P/EBITDA
—
P/OCF
—
P/FCF
—
P/E
—
BVPS
2,2
EPS
—
Market Cap
Market Cap
52,1M
EV
37,2M
EV/Revenue
2,1
EV/EBITDA
-2,9
EV/EBIT
-2,8
Payout
Dividend Per Share
0
Dividend Yield
0%
Buyback Yield
0%
Total Yield
0%
Payout
0%
Retained Earnings
-5,7M
Profitability
Gross Margin
36,4%
EBITDA Margin
—
EBIT Margin
—
Net Margin
—
D&A/EBITDA
0%
R&D/Revenue
36,6%
Capex/Revenue
1%
Capex/D&A
45,2%
Capex/OCF
-2,5%
SBC/OCF
—
% PPE
7,5%
% Goodwill
0%
ROE
—
ROIC
—
Growth
CAGR Revenue 5Y
2,9%
CAGR Op. Income 5Y
31,2%
CAGR Net Income 5Y
83,4%
CAGR EPS 5Y
48,5%
CAGR OCF 5Y
19,8%
Leverage
N.D./EBITDA
1,2
Debt/Equity
0%
Current Ratio
8,7
Quick Ratio
3,9
Interest Coverage
—
Premium
- Unrestricted access
- Unlimited data history
- Analysis videos
- Quarterly highlights
- Customizable financials table
- Ranking
- Discussions
...and much more!